|
|
||||||||
|
FJ
EXPRESS SUMMARY ARTICLE The Full-length version of this article is also available, published online August 25, 2005 as doi:10.1096/fj.05-3748fje. |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Neurology, Universität des Saarlandes, Homburg, Germany
1 Correspondence: E-mail: tkorn{at}rics.bwh.harvard.edu
SPECIFIC AIMS
Glutamate excitotoxicity has been proposed to be of pathogenic relevance in autoimmune inflammatory disorders of the central nervous system (CNS) causing damage to both neurons and oligodendroglial cells. We studied the impact of autoantigen-activated myelin basic protein (MBP) specific T cells on the functional expression of GLAST that belongs to the predominant astrocytic transport proteins to clear extracellular glutamate.
PRINCIPAL FINDINGS
1. Interaction with activated MBP specific T cells decreases glutamate transport capacity in astrocytes
After coculture with MBP-specific encephalitogenic T cells, rat primary astrocytes exhibited reduced glutamate uptake capacities in vitro. vmax values were 7010 ± 447 pmol mg1 min1 and 5830 ± 447 pmol mg1 min1 in naive astrocytes and in astrocytes recovered from coculture with resting T cells; maximum glutamate uptake rates in astrocyte monolayers were suppressed to 4340 ± 178 pmol mg1 min1 after incubation with MBP specific T cells activated in the coculture dish through the presence of antigen and to 3860 ± 437 pmol mg1 min1 after incubation with preactivated T cell blasts, respectively. Thus, exposure of astrocyte monolayers to autoreactive T cells in the presence of their specific antigen or to purified preactivated T cell blasts led to a significant decrease in vmax of L-[3H]-glutamate uptake compared with naive astrocytes (P<0.002 and P<0.0005) or with astrocytes that had been cocultured with resting T cells (P<0.03 and P<0.005). The respective Km values remained unchanged. These results indicated that, in vitro, the glutamate clearance capacity of astrocytes was significantly impaired by the presence of autoreactive T cells depending on their activation level.
2. MBP specific T cells decrease the expression of GLAST in astrocytes by secretion of TNF-
After coculture with autoreactive T cells, GLAST protein levels were reduced in astrocytes. Referred to naive astrocytes, the decrease of GLAST was negligible after coculture with resting T cells, but became significant when astrocytes had been exposed to MBP specific T cells either activated during coculture or preactivated and cocultured in the presence of IL-2. In the first setting reflecting local autoantigen activation, high TNF-
levels were accompanied by marked concentrations of IL-10; in the second scenario reflecting encounter of systemically activated T cells, TNF-
was lower and IL-10 absent in the coculture supernatant. To unravel the mechanism of this T cell-triggered down modulation of GLAST, astrocytes were incubated with variably diluted cell-free supernatants from freshly activated and purified T cell blasts. The supernatants suppressed the expression of GLAST in astrocytes concentration-dependently (Fig. 1
A). This argued in favor of a humoral factor inducing the decrease of astrocytic GLAST protein in the coculture settings. Since the predominant cytokines in the T cell blast supernatant were IFN-
and TNF
(Fig. 1B
), we focused on these first. Indeed, the down-regulation of GLAST could be blocked when the supernatant was preincubated with a neutralizing anti-TNF-
antibody (Fig. 1C
). Recombinant TNF-
recapitulated the GLAST-reducing effect. A dose-dependent decrease of GLAST protein was evident in astrocytes exposed to increasing concentrations of TNF-
(Fig. 1D
). In contrast to TNF-
, recombinant IFN-
did not induce any significant change in the astrocytic expression level of GLAST as illustrated by immunoblot and flow cytometry (Fig. 1E
).
|
3. Astroglial expression of GLAST is strongly reduced in experimental autoimmune encephalomyelits (EAE)
We wished to test whether the decrease of GLAST triggered by autoreactive T cells was paralleled in vivo. We used an adoptive transfer EAE model that simulates inflammatory features of multiple sclerosis (MS). Histolopathologic analyses of cerebella and spinal cords were performed on day 6 after cell transfer when animals were paraplegic. At this point, PBS-injected control-rats were healthy and showed intense GLAST expression in the cerebellar molecular layer and the spinal cord white matter (Fig. 2
A, G). In contrast, molecular layer and spinal cord white matter appeared virtually cleared of GLAST in paraplegic EAE-rats (Fig. 2B, H
). On day 6 after cell transfer, GFAP staining as marker for astrocytes did not seem to be altered due to autoimmune inflammation (Fig. 2C, D, I, K
). This argued against some unspecific response of astrocytic protein expression. The down-regulation of GLAST in astrocytes was widespread and not confined to inflammatory infiltrates that were mainly perivascular in the cerebellum (Fig. 2F
) and scattered in the spinal cord (Fig. 2M
) as illustrated by ED1 staining for macrophages. These findings indicated that in vivo also, a humoral factor (most likely TNF-
) might be operative to decrease the expression of GLAST in astrocytes in the course of T cell-triggered autoimmunity.
|
CONCLUSIONS AND SIGNIFICANCE
Glutamate excitotoxicity has long been recognized as pathogenic principle in ischemic brain lesions and degenerative disorders of the CNS. Only recently, it has been reported that glutamate receptor blocking agents were able to protect neurons and oligodendrocytes during EAE. Thus, excess extracellular glutamate might contribute to tissue damage apart from destructive processes that emanate directly from autoimmune inflammatory infiltrates. Astrocytes are the principal players in clearing glutamate from the extracellular space and have great spare capacities regarding secondary active glutamate reuptake. One of the predominant proteins to mediate glutamate transport in astrocytes is GLAST. Particularly in the cerebellar molecular layer it is very likely that synaptic spillover of glutamate and also ambient glutamate levels are controlled by astrocytes expressing GLAST.
In the present study, we show that interaction of astrocytes with autoantigen-activated encephalitogenic T cells leads to a partial loss of astrocytic glutamate uptake capacity on the basis of a substantial decrease of GLAST expression. It is evident that MBP specific T cells need to be activated but do not have to be in direct contact with astrocytes to mediate the down-regulation of astrocytic GLAST protein. T cell derived TNF-
seems to be the driving agent. In accordance with the TNF-
responsiveness of the EAAT1 promoter, the human homologue of rat GLAST, we assume a transcriptional mode of regulation of GLAST expression by TNF-
. The delayed down-regulation of GLAST in the range of 48 h is in line with this concept. The decrease of GLAST in astrocytes upon TNF-
is dose-dependent. Interestingly, IL-10 might partially antagonize the TNF-
mediated down modulation of GLAST in astrocytes since higher TNF-
levels do not further decrease GLAST in T cell/astrocyte cocultures when on site-stimulation of T cells allows for production of IL-10. TNF-
antagonizing properties of IL-10 in terms of astrocyte effector functions have been described previously. TNF-
mediated suppression of glutamate uptake into astrocytes has been reported in infectious diseases of the CNS. HTLV-1 infected T cells are likewise thought to impair astrocytic glutamate uptake by secretion of viral proteins or cytokines. Thus, excess extracellular glutamate accumulation might result and subsequent glutamate excitotoxicity could be a common pathogenic effector limb in chronic infectious and autoimmune inflammatory CNS disorders (Fig. 3
).
|
This may offer an explanation for the observation that in MS, markers of axonal and oligodendrocyte precursor integrity such as N-acetyl aspartate (as measured by magnetic resonance spectroscopy) are decreased early in the disease course and distant from truly demyelinating lesions. It is an open question whether, besides blockage of glutamate receptors, differential targeting of TNF-
signaling pathways or strengthening of IL-10 effects might provide tools to combat glutamate excitotoxicity in chronic autoimmune inflammatory disorders of the CNS.
FOOTNOTES
To read the full text of this article, go to http://www.fasebj.org/cgi/doi/10.1096/fj.05-3748fje;
This article has been cited by other articles:
![]() |
S. K. Garg, R. Banerjee, and J. Kipnis Neuroprotective Immunity: T Cell-Derived Glutamate Endows Astrocytes with a Neuroprotective Phenotype J. Immunol., March 15, 2008; 180(6): 3866 - 3873. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Domercq, M. V. Sanchez-Gomez, C. Sherwin, E. Etxebarria, R. Fern, and C. Matute System xc- and Glutamate Transporter Inhibition Mediates Microglial Toxicity to Oligodendrocytes J. Immunol., May 15, 2007; 178(10): 6549 - 6556. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |